Proteomics

Dataset Information

0

Crenigacestat inhibits osteogenic differentiation of human valve interstitial cells and seems promising for treatment of cardiovascular calcification


ABSTRACT: Vascular calcification is common pathology various forms of which presented in the half of humans. Calcific aortic valve disease (CAVD) is one of the most dangerous forms of vascular calcification. Despite high mortality there is no target therapy against CAVD. Thus, we tested crenigacestat (LY3039478), inhibitor of Notch-signaling, and shRNA against RBPJk for inhibition of osteogenic differentiation of velve intersticial cells (VICs) in vitro. Both of them effectivelly enhibited osteogenic differentiation and we performed proteomics analysis do describe molecular mechanisms of their effect. Presented dataset contain results of shotgun proteomics analysis with ion mobility in TimsToF Pro instrument (in DDA PASEF mode) of VICs in classic osteogenic medium (OM) and OM supplemented with crenigacestat, DMSO or shCSL.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Valve Cell, Cell Culture

DISEASE(S): Aortic Valve Stenosis

SUBMITTER: Arseniy Lobov  

LAB HEAD: Anna B. Malashicheva

PROVIDER: PXD029632 | Pride | 2022-10-04

REPOSITORIES: Pride

Similar Datasets

2021-06-09 | PXD015223 | Pride
2012-01-05 | E-GEOD-34842 | ArrayExpress